Free Access
Reprod. Nutr. Dev.
Volume 46, Number 1, January-February 2006
Page(s) 97 - 104
Published online 27 January 2006
References of Reprod. Nutr. Dev. 46 97-104
  1. Roberts RM, Ezashi T, Rosenfeld CS, Ealy AD, Kubisch HM. Evolution of the interferon-$\tau$ genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reproduction Suppl 2003, 61: 239-251.
  2. Hernandez-Ledezma JJ, Sikes JD, Murphy CN, Watson AJ, Schultz GA, Roberts RM. Expression of bovine trophoblast interferon in conceptuses derived by in vitro techniques. Biol Reprod 1992, 47: 374-380 [CrossRef] [PubMed].
  3. Kubisch HM, Larson MA, Ealy AD, Murphy CN, Roberts RM. Genetic and environmental determinants of interferon-$\tau$ secretion by in vivo- and in vitro-derived bovine blastocysts. Anim Reprod Sci 2001, 66: 1-13 [CrossRef] [PubMed].
  4. Stojkovic M, Buttner M, Zakhartchenko V, Riedl J, Reichenbach HD, Wenigerkind H, Brem G, Wolf E. Secretion of interferon-tau by bovine embryos in long-term culture: comparison of in vivo derived, in vitro produced, nuclear transfer and demi-embryos. Anim Reprod Sci 1999, 55: 151-162 [CrossRef] [PubMed].
  5. Kubisch HM, Larson MA, Roberts RM. Relationship between age at blastocyst formation and interferon-$\tau$ secretion by in vitro-derived bovine embryos. Mol Reprod Dev 1998, 49: 254-260 [CrossRef] [PubMed].
  6. Larson MA, Kubisch HM. The effects of group size on development and interferon-$\tau$ secretion by in vitro fertilized and cultured bovine blastocysts. Hum Reprod 1999, 14: 2075-2079 [CrossRef] [PubMed].
  7. Kubisch HM, Larson MA, Kiesling DO. Control of interferon-$\tau$ secretion by in vitro-derived bovine blastocysts during extended culture and outgrowth formation. Mol Reprod Dev 2001, 58: 390-397 [CrossRef] [PubMed].
  8. Larson MA, Kimura K, Kubisch HM, Roberts RM. Sexual dimorphism among bovine embryos in their ability to make the transition to expanded blastocyst and in the expression of the signaling molecule IFN-$\tau$. Proc Natl Acad Sci USA 2001, 98: 9677-9682 [CrossRef] [PubMed].
  9. Kimura K, Spate LD, Green MP, Murphy CN, Seidel GE Jr, Roberts RM. Sexual dimorphism in interferon-tau production by in vivo-derived bovine embryos. Mol Reprod Dev 2004, 67: 193-199 [CrossRef] [PubMed].
  10. Wrenzycki C, Herrmann D, Keskintepe L, Martins A, Sirisathien S, Brackett B, Niemann H. Effects of culture system and protein supplementation on mRNA expression in pre-implantation bovine embryos. Hum Reprod 2001, 16: 893-901 [CrossRef] [PubMed].
  11. Lonergan P, Rizos D, Gutierrez-Adan A, Moreira PM, Pintado B, de la Fuente J, Boland MP. Temporal divergence in the pattern of messenger RNA expression in bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. Biol Reprod 2003, 69: 1424-1431 [CrossRef] [PubMed].
  12. Farin CE, Imakawa K, Roberts RM. In situ localization of mRNA for the interferon, ovine trophoblast protein-1, during early embryonic development of the sheep. Mol Endocrinol 1989, 3: 1099-1107 [PubMed].
  13. Farin CE, Imakawa K, Hansen TR, McDonnell JJ, Murphy CN, Farin PW, Roberts RM. Expression of trophoblastic interferon genes in sheep and cattle. Biol Reprod 1990, 43: 210-218 [CrossRef] [PubMed].
  14. Wooding FB, Morgan G, Roberts RM. Quantitative immunogold ultracryomicrotome studies of the distribution of periimplantation proteins in the sheep. Cell Tissue Res 1991, 265: 83-93 [CrossRef] [PubMed].
  15. Talbot NC, Caperna TJ, Edwards JL, Garrett W, Wells KD, Ealy AD. Bovine blastocyst-derived trophectoderm and endoderm cell cultures: interferon tau and transferrin expression as respective in vitro markers. Biol Reprod 2000, 62: 235-247 [CrossRef] [PubMed].
  16. Pesce M, Anastassiadis K, Schöler HR. Oct-4: lessons of totipotency from embryonic stem cells. Cells Tissues Organs 1999, 165: 144-152 [CrossRef] [PubMed].
  17. Pesce M, Schöler HR. Oct-4: control of totipotency and germline determination. Mol Reprod Dev. 2000, 55: 452-457 [CrossRef] [PubMed].
  18. Ezashi T, Roberts RM. Regulation of interferon-$\tau$ gene promoters by growth factors that target the Ets-2 composite enhancer: A possible model for maternal control of IFN-$\tau$ production by the conceptus during early pregnancy. Endocrinology 2004, 145: 4452-4460 [CrossRef] [PubMed].
  19. Roberts RM, Ezashi T, Das P. Trophoblast gene expression: transcription factors in the specification of early trophoblast. Reprod Biol Endocrinol 2004, 2: 47 [CrossRef] [PubMed].
  20. Stewart DM, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. Endocrinology 2001, 142: 98-107 [CrossRef] [PubMed].
  21. Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell 1984, 39: 499-509 [CrossRef] [PubMed].
  22. LaCasse EC, Lefebvre YA. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucl Acids Res. 1995, 23: 1647-1656.
  23. Kume S, Muto A, Aruga J, Nakagawa T, Michikawa T, Furuichi T, Nakade S, Okano H, Mikoshiba K. The Xenopus IP3 receptor: structure, function, and localization in oocytes and eggs. Cell 1993, 73: 555-570 [CrossRef] [PubMed].
  24. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 1987, 51: 1079-1090 [CrossRef] [PubMed].
  25. Tsuchiya E, Uno M, Kiguchi A, Masuoka K, Kanemori Y, Okabe S, Mikayawa T. The Saccharomyces cerevisiae NPS1 gene, a novel CDC gene which encodes a 160 kDa nuclear protein involved in G2 phase control. EMBO J 1992, 11: 4017-4026 [PubMed].
  26. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320: 134-139 [CrossRef] [PubMed].
  27. Wilks AF. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci USA 1989, 86: 1603-1607 [PubMed].
  28. Velazquez L, Fellous M, Stark GR, Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 1992, 70: 313-322 [CrossRef] [PubMed].
  29. Subramaniam PS, Larkin J 3rd, Mujtaba MG, Walter MR, Johnson HM. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci 2000, 113: 2771-2781 [PubMed].
  30. Subramaniam PS, Johnson HM. Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1$\alpha$. J Immunol 2002, 169: 1959-1969 [PubMed].
  31. Ahmed CM, Burkhart MA, Mujtaba MG, Subramaniam P, Johnson HM. The role of IFNgamma nuclear localization sequence in intracellular function. J Cell Sci 2003, 116: 3089-3098 [CrossRef] [PubMed].
  32. Subramaniam PS, Flowers LO, Haider SM, Johnson HM. Signal transduction mechanism of a peptide mimetic of interferon-gamma. Biochemistry 2004, 43: 5445-5454 [CrossRef] [PubMed].